DEA controlled substances
Schedule V drugs
10 medicines are listed in FDA's NDC Directory with DEA schedule V; 7 are listed from generic labelers (directory read October 8, 2026).
Which medicines are schedule V?
The schedule is the one listed on the products; the DEA's own schedules decide the law.
| Medicine | Brand names | Generic labelers (all forms) | Pharmacy cost | Boxed warning | Shortage | Recalls since 2012 |
|---|---|---|---|---|---|---|
| Pregabalin | Lyrica | 52 labelers | $0.0571 per capsule 100 mg capsule | No | No current entry | 5 |
| Lacosamide | Vimpat, Motpoly | 57 labelers | $0.174 per tablet 100 mg tablet | No | No current entry | 8 |
| Acetaminophen and codeine | none listed | 24 labelers | $0.256 per tablet 3 tablet | Yes | No current entry | 5 |
| Brivaracetam | Briviact | 16 labelers | $0.259 per tablet 100 mg tablet | No | No current entry | 1 |
| Atropine and diphenoxylate | Lomotil | 19 labelers | $0.139 per tablet 2.5-0.025 mg tablet | No | No current entry | 2 |
| Cenobamate | Xcopri | none listed | $39.87 per tablet 100 mg tablet | No | No current entry | 0 |
| Codeine and promethazine | none listed | 5 labelers | $0.0697 per mL Promethazine-codeine solution | Yes | No current entry | 0 |
| Lasmiditan | Reyvow | none listed | $88.77 per tablet 100 mg tablet | No | A presentation being discontinued | 0 |
| Codeine and phenylephrine and promethazine | none listed | 1 labeler | n/a | Yes | No current entry | 0 |
| Ganaxolone | Ztalmy | none listed | n/a | No | No current entry | 0 |
Source: FDA NDC Directory (DEA schedule field) via openFDA, October 8, 2026; the DEA schedules